| Jason Holt, MD | |
|
4019 N Remington Dr, Fayetteville, AR 72703-6344 | |
| (479) 595-8192 | |
| (479) 442-1748 |
| Full Name | Jason Holt |
|---|---|
| Gender | Male |
| Speciality | Interventional Pain Management |
| Experience | 20 Years |
| Location | 4019 N Remington Dr, Fayetteville, Arkansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932328267 | NPI | - | NPPES |
| 184323001 | Medicaid | AR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208VP0014X | Pain Medicine - Interventional Pain Medicine | E-6510 (Arkansas) | Primary |
| 207L00000X | Anesthesiology | E-6510 (Arkansas) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Washington Regional Medical Center | Fayetteville, AR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Interventional Pain Specialists Of Nwa Pllc | 6901081538 | 2 |
News Archive
Ardea Biosciences, Inc. has announced positive results from a Phase 1 study in normal, healthy volunteers of RDEA594, its lead product candidate for the treatment of hyperuricemia and gout, and a pilot Phase 2a proof-of-concept study in gout patients of RDEA594's prodrug, RDEA806 (RDEA806 is converted to RDEA594 in the body).
Valeant Pharmaceuticals International announced today that it has priced its previously announced private placement of $400 million of 7.625% senior unsecured notes due 2020. The principal amount was increased from the previously announced $350 million.
According to a new study by British researchers probiotic yogurt drinks containing "good" bacteria help patients avoid the diarrhea caused by antibiotics.
Three of the world's top lung associations have published a new international multidisciplinary classification of lung adenocarcinoma, the first revision to the classification in six years.
Black patients having a heart attack wait longer at hospitals than white patients to get advanced procedures that will restore blood flow to their hearts, according to a University of Michigan Health System study.
› Verified 7 days ago
| Entity Name | Interventional Pain Specialists Of Nwa Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295032407 PECOS PAC ID: 6901081538 Enrollment ID: O20110426000462 |
News Archive
Ardea Biosciences, Inc. has announced positive results from a Phase 1 study in normal, healthy volunteers of RDEA594, its lead product candidate for the treatment of hyperuricemia and gout, and a pilot Phase 2a proof-of-concept study in gout patients of RDEA594's prodrug, RDEA806 (RDEA806 is converted to RDEA594 in the body).
Valeant Pharmaceuticals International announced today that it has priced its previously announced private placement of $400 million of 7.625% senior unsecured notes due 2020. The principal amount was increased from the previously announced $350 million.
According to a new study by British researchers probiotic yogurt drinks containing "good" bacteria help patients avoid the diarrhea caused by antibiotics.
Three of the world's top lung associations have published a new international multidisciplinary classification of lung adenocarcinoma, the first revision to the classification in six years.
Black patients having a heart attack wait longer at hospitals than white patients to get advanced procedures that will restore blood flow to their hearts, according to a University of Michigan Health System study.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jason Holt, MD 4019 N Remington Dr, Fayetteville, AR 72703-6344 Ph: (479) 595-8192 | Jason Holt, MD 4019 N Remington Dr, Fayetteville, AR 72703-6344 Ph: (479) 595-8192 |
News Archive
Ardea Biosciences, Inc. has announced positive results from a Phase 1 study in normal, healthy volunteers of RDEA594, its lead product candidate for the treatment of hyperuricemia and gout, and a pilot Phase 2a proof-of-concept study in gout patients of RDEA594's prodrug, RDEA806 (RDEA806 is converted to RDEA594 in the body).
Valeant Pharmaceuticals International announced today that it has priced its previously announced private placement of $400 million of 7.625% senior unsecured notes due 2020. The principal amount was increased from the previously announced $350 million.
According to a new study by British researchers probiotic yogurt drinks containing "good" bacteria help patients avoid the diarrhea caused by antibiotics.
Three of the world's top lung associations have published a new international multidisciplinary classification of lung adenocarcinoma, the first revision to the classification in six years.
Black patients having a heart attack wait longer at hospitals than white patients to get advanced procedures that will restore blood flow to their hearts, according to a University of Michigan Health System study.
› Verified 7 days ago
Jared Ennis, MD Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 4019 N Remington Dr, Fayetteville, AR 72703 Phone: 479-595-8192 Fax: 479-442-1748 |